Literature DB >> 18308489

Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin.

Benjaporn Treetharnmathurot1, Chitchamai Ovartlarnporn, Juraithip Wungsintaweekul, Ruth Duncan, Ruedeekorn Wiwattanapatapee.   

Abstract

PEGylated proteins are routinely used as therapeutics, but systematic studies of the effect of PEG molecular weight and linking chemistry on the biological activity and particularly the thermal stability of the conjugated protein are rarely made. Here, activated monomethoxypolyethylene glycol (mPEG)s (Mw 1100, 2000 and 5000 g/mol) were prepared using succinic anhydride (SA), cyanuric chloride (CC) or tosyl chloride (TC) and used to synthesise a library of trypsin conjugates. The enzyme activity (KM, Vmax and Kcat) of native trypsin and the mPEG-modified trypsin conjugates was compared using N-benzoyl-l-arginine p-nitroanilide (BAPNA) as a substrate, and their thermal stability determined using both BAPNA and N-alpha-benzoyl-l-arginine ethyl ester hydrochloride (BAEE) as substrates to measure amidase and esterase activity respectively. The effect of conjugate chemistry on trypsin autolysis was also examined at 40 degrees C. PEG-trypsin conjugates containing the higher molecular weight of mPEG (5000 g/mol) were more stable than free trypsin, and the conjugate containing CC-mPEG 5000 g/mol had the best thermal stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308489     DOI: 10.1016/j.ijpharm.2008.01.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity.

Authors:  Andrew J Keefe; Shaoyi Jiang
Journal:  Nat Chem       Date:  2011-12-11       Impact factor: 24.427

Review 2.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

3.  Conformational and aggregation properties of a PEGylated alanine-rich polypeptide.

Authors:  Ayben Top; Christopher J Roberts; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2011-05-09       Impact factor: 6.988

4.  Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates.

Authors:  José A Rodríguez-Martínez; Izarys Rivera-Rivera; Ricardo J Solá; Kai Griebenow
Journal:  Biotechnol Lett       Date:  2009-02-18       Impact factor: 2.461

5.  A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease.

Authors:  Luca Ronda; Marialaura Marchetti; Riccardo Piano; Anastasia Liuzzi; Romina Corsini; Riccardo Percudani; Stefano Bettati
Journal:  Pharm Res       Date:  2017-05-15       Impact factor: 4.200

6.  Synthesis and application in polypropylene of a novel of phosphorus-containing intumescent flame retardant.

Authors:  Jian-Dong Zuo; Shu-Mei Liu; Qi Sheng
Journal:  Molecules       Date:  2010-10-28       Impact factor: 4.411

7.  Insight into the molecular mechanism behind PEG-mediated stabilization of biofluid lipases.

Authors:  Bianca Pérez; Andrea Coletta; Jannik N Pedersen; Steen V Petersen; Xavier Periole; Jan Skov Pedersen; Richard B Sessions; Zheng Guo; Adam Perriman; Birgit Schiøtt
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

8.  Artificial environments for the co-translational stabilization of cell-free expressed proteins.

Authors:  Lei Kai; Volker Dötsch; Ralf Kaldenhoff; Frank Bernhard
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction.

Authors:  Shanyuan Zheng; Xiaoling Li; Yibo Zhang; Qiang Xie; Yum-Shing Wong; Wenjie Zheng; Tianfeng Chen
Journal:  Int J Nanomedicine       Date:  2012-07-23

10.  Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation.

Authors:  Jia-Dong Zheng; Yan He; Heng-Yuan Yu; Yuan-Li Liu; Yi-Xuan Ge; Xue-Ting Li; Xue Li; Yan Wang; Meng-Ru Guo; Yi-Lin Qu; Xiao-Fa Qin; Ming-Shan Jiang; Xiu-Hong Wang
Journal:  World J Gastroenterol       Date:  2019-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.